AnalystsJoseph PantginisJoseph Pantginis's Stock Forecasts
AnalystsJoseph Pantginis
Sectors:
Analyst Ranking
Top 14%
#590 out of 4233 analysts
Average Return
+2.09%
Win Rate
38%96 out of 250
Risk vs Reward
Poor
Good
Joseph Pantginis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Celldex Therapeutics IncCLDX | +1,183.78% | $1.85 | $23.75 | 2020-03-27 - 2021-03-26 | Buy |
Biomea Fusion IncBMEA | +608.98% | $4.79 | $33.96 | 2022-06-02 - 2023-05-31 | Buy |
Biomea Fusion IncBMEA | +356.45% | $7.44 | $33.96 | 2023-01-13 - 2023-05-31 | Buy |
Avid Bioservices IncCDMO | +272.06% | $4.51 | $16.78 | 2020-03-11 - 2021-03-11 | Buy |
Immune Design CorpIMDZ | +216.22% | $1.85 | $5.85 | 2018-10-12 - 2019-04-01 | Buy |
Joseph Pantginis Analyst Color
Get additional color on Joseph Pantginis's coverage of popular stocks
Joseph Pantginis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Celldex Therapeutics IncCLDX | 11 | Buy | $73.00 | +129.56% | Reiterates | 2 days ago |
Palatin Technologies IncPTN | 6 | Buy | $70.00 | +2,757.14% | Reiterates | 2 days ago |
Iovance Biotherapeutics IncIOVA | 8 | Buy | $38.00 | +334.78% | Reiterates | 3 days ago |
Tempest Therapeutics IncTPST | 6 | Buy | $35.00 | +2,187.58% | Reiterates | 3 days ago |
Aravive IncARAV | 8 | Buy | $12.00 | +605.88% | Reiterates | 7 days ago |
Pds Biotechnology CorpPDSB | 9 | Buy | $21.00 | +119.21% | Reiterates | 7 days ago |
Shattuck Labs IncSTTK | 6 | Buy | $28.00 | +910.83% | Reiterates | 7 days ago |
Lisata Therapeutics IncLSTA | 4 | Buy | $15.00 | +265.85% | Reiterates | 7 days ago |
Clene IncCLNN | 9 | Buy | $15.00 | +1,446.39% | Reiterates | 7 days ago |
Onconova Therapeutics IncONTX | 5 | Buy | $11.00 | +840.17% | Reiterates | 7 days ago |
Atyr Pharma IncLIFE | 7 | Buy | $35.00 | +1,441.85% | Reiterates | 10 days ago |
Krystal Biotech IncKRYS | 10 | Buy | $139.00 | +17.95% | Maintains | 11 days ago |
Cytokinetics IncCYTK | 11 | Buy | $49.00 | +30.01% | Reiterates | 11 days ago |
Biora Therapeutics IncBIOR | 2 | Buy | $65.00 | +1,350.89% | Reiterates | 17 days ago |
Aprea Therapeutics IncAPRE | 2 | Buy | $20.00 | +419.48% | Reiterates | 17 days ago |
Actinium Pharmaceuticals IncATNM | 8 | Buy | $53.00 | +538.55% | Reiterates | 17 days ago |
Biomx IncPHGE | 2 | Buy | $7.00 | +1,844.44% | Maintains | 17 days ago |
Mustang Bio IncMBIO | 2 | Buy | $7.00 | +9.55% | Reiterates | 18 days ago |
Decibel Therapeutics IncDBTX | 4 | Buy | $23.00 | +469.31% | Reiterates | 21 days ago |
Armata Pharmaceuticals IncARMP | 6 | Buy | $7.00 | +422.39% | Reiterates | 21 days ago |
Lineage Cell Therapeutics IncLCTX | 2 | Buy | $7.00 | +455.56% | Reiterates | 21 days ago |
Alpine Immune Sciences IncALPN | 1 | Buy | $11.00 | +10.44% | Reiterates | 21 days ago |
Vyne Therapeutics IncVYNE | 4 | Buy | $28.00 | +345.15% | Reiterates | 21 days ago |
Astria Therapeutics IncATXS | 6 | Buy | $20.00 | +82.82% | Reiterates | 21 days ago |
Tenaya Therapeutics IncTNYA | 3 | Buy | $18.00 | +150.00% | Reiterates | 22 days ago |
Atreca IncBCEL | 4 | Buy | $25.00 | +2,400.00% | Reiterates | 22 days ago |
Biocardia IncBCDA | 3 | Buy | $9.00 | +408.47% | Reiterates | 22 days ago |
Kura Oncology IncKURA | 5 | Buy | $32.00 | +140.24% | Reiterates | 22 days ago |
Aptose Biosciences IncAPTO | 4 | Buy | $12.00 | +2,826.83% | Reiterates | 24 days ago |
Viking Therapeutics IncVKTX | 7 | Buy | $33.00 | +50.27% | Reiterates | 25 days ago |
Panbela Therapeutics IncPBLA | 2 | Buy | $7.00 | +3,011.11% | Reiterates | a month ago |
Rigel Pharmaceuticals IncRIGL | 8 | Buy | $15.00 | +971.43% | Reiterates | a month ago |
Biomea Fusion IncBMEA | 7 | Buy | $37.00 | +8.95% | Reiterates | a month ago |
Checkpoint Therapeutics IncCKPT | 5 | Buy | $34.00 | +1,187.88% | Maintains | a month ago |
Xenetic Biosciences IncXBIO | 3 | Buy | $40.00 | +1,240.03% | Reiterates | 2 months ago |
Omniab IncOABI | 2 | Buy | $11.00 | +154.63% | Reiterates | 2 months ago |
Pharming Group NvPHAR | 3 | Buy | $37.00 | +208.33% | Reiterates | 2 months ago |
Capricor Therapeutics IncCAPR | 5 | Buy | $18.00 | +297.35% | Reiterates | 3 months ago |
Esperion Therapeutics IncESPR | 3 | Buy | $22.00 | +1,517.65% | Reiterates | 3 months ago |
Compass Therapeutics IncCMPX | 3 | Buy | $10.00 | +244.83% | Reiterates | 3 months ago |
Xoma CorpXOMA | 2 | Buy | $69.00 | +305.88% | Reiterates | 3 months ago |
Nuvectis Pharma IncNVCT | 3 | Buy | $21.00 | +20.00% | Reiterates | 3 months ago |
Biophytis SaBPTS | 3 | Buy | $150.00 | +6,134.41% | Reiterates | 3 months ago |
Imv IncIMVIQ | 1 | Buy | $65.00 | +7,797.93% | Reiterates | 4 months ago |
Genenta Science SpaGNTA | 2 | Buy | $25.00 | +309.70% | Reiterates | 4 months ago |
Applied Genetic Technologies CorpAGTC | 3 | Hold | N/A | N/A | Downgrades | 7 months ago |
Akouos IncAKUS | 2 | Hold | N/A | N/A | Downgrades | 7 months ago |
Humanigen IncHGEN | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Genocea Biosciences IncGNCAQ | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Sierra Oncology IncSRRA | 1 | Hold | $55.00 | N/A | Downgrades | a year ago |
Sio Gene Therapies IncSIOX | 3 | Buy | $7.00 | N/A | Maintains | a year ago |
Beyondspring IncBYSI | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Essa Pharma IncEPIX | 3 | Buy | $32.00 | N/A | Maintains | 2 years ago |
Biolinerx LtdBLRX | 1 | Buy | $19.00 | N/A | Maintains | 2 years ago |
Ligand Pharmaceuticals IncLGND | 7 | Buy | $310.00 | N/A | Maintains | 2 years ago |
Strata Skin Sciences IncSSKN | 1 | Buy | $3.00 | N/A | Upgrades | 3 years ago |
Principia Biopharma IncPRNB | 4 | Hold | $100.00 | N/A | Downgrades | 3 years ago |
Avid Bioservices IncCDMO | 2 | Buy | $9.00 | N/A | Reiterates | 3 years ago |
Immune Design CorpIMDZ | 1 | Buy | $7.75 | N/A | Maintains | 5 years ago |
Tg Therapeutics IncTGTX | 2 | Buy | $33.00 | N/A | Assumes | 6 years ago |
Soligenix IncSNGX | 1 | Buy | $165.00 | N/A | Initiates Coverage On | 6 years ago |
Fortress Biotech IncFBIO | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 6 years ago |
Pieris Pharmaceuticals IncPIRS | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 6 years ago |
Verastem IncVSTM | 1 | Buy | $6.50 | N/A | Reiterates | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.